SciELO - Scientific Electronic Library Online

vol.43 issue3Frequency and susceptibility percentile of bacteria isolated in patients assisted in the intensive care unit of the General Hospital of FortalezaDiagnostic investigation of inborn errors of metabolism in a university hospital author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Jornal Brasileiro de Patologia e Medicina Laboratorial

Print version ISSN 1676-2444On-line version ISSN 1678-4774


DELLAVANCE, Alessandra  and  ANDRADE, Luís Eduardo Coelho. How to interpret and appropriately appreciate the antinuclear antibody test. J. Bras. Patol. Med. Lab. [online]. 2007, vol.43, n.3, pp.157-168. ISSN 1676-2444.

The tradicional fluorescent antinuclear antibody test (ANA) has required constant update efforts from personel involved in performing and interpreting its results. The methodological advances have brought up a considerable improvement in the test’s sensitivity and, consequentely, a decrease in its specificity. This has resulted in an increasing number of positive tests in apparently healthy subjects. However, there are some peculiar features associated with the auto-antibodies in patients with autoimmune diseases that are not present in those observed in healthy subjects. The objective of the present review is to bring an approach on the most important points to be considered in the analysis and evalution of an ANA test that might help in the identification of patients with autoimmune disease. Title and immunofluorescence pattern are discussed as important parameters and they are important in the evaluation of ANA and in the reflex demand for further tests for specific autoantibodies. The basic concepts of the National Consensus on Standardization of ANA-HEp-2 Report are posted. Finally, we explore the possible meanings of a positive ANA test in a patient without objective evidence of autoimmune disease.

Keywords : Antinuclear antibodies; HEp-2 cells; Autoantibodies; Autoimmune diseases; Serological markers.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License